Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Getinge    GETI B   SE0000202624

GETINGE (GETI B)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Getinge : launches the new Advanta V12 - 32mm Balloon Expandable Covered Stent.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/21/2017 | 01:24pm CEST

April 21, 2017
London, UK

Getinge is proud to announce the launch of the Advanta™ V12™ 32mm length* balloon expandable covered stent at Charing Cross International Congress. This is a much needed addition to the Advanta™ V12™ product offering and will allow clinicians additional treatment options for optimal patient outcomes.

With over 200 clinical publications and close to 500,000 patients successfully treated worldwide, this latest product line extension will add to the rapidly growing body of evidence supporting the safety and efficacy of Getinge's covered stent technology.

The Advanta™ V12™ covered stent is a low profile, pre-mounted balloon expandable covered stent made of a radial expandable 316L stainless steel that is completely encapsulated with a patented one-piece PTFE covering technology.  Getinge's proprietary covering technology creates a microporous PTFE layer that completely encapsulates the stainless steel stent and allows for uniform expansion without ridges or folds in the material being formed.  V12 is customizable with the ability to post dilate to meet each patients anatomical needs. 

Getinge will also host, at Charing Cross, in partnership with VASCULAR INTERNATIONAL, a series of masterclass workshops in which participants will have hands-on experience using the new Advanta™ V12™ 32mm and learn the latest techniques from the experts. `It is extremely important to provide appropriate training and guidance to the medical community and these workshops allow not only hands-on experience on training models but also provide the participants with the opportunity to network and build relationships with medical experts" says Markus Stirner-Schilling, Vice President, Marketing & Academy, Getinge, Europe, Middle East & Africa.

Getinge will also support two very important satellite symposia with a focus on Advanta™ V12™ and new INTERGARD SYNERGY data.

*32mm lengths not available in all regions

About Getinge at Charing Cross:

Registered visitors are invited to visit Getinge on booth 170 from 25-28 April 2017, Olympia Grand, London, UK.

For further information, please contact

Tracey Dawe
Director Communications and Congress Management Europe, Middle East & Africa
Phone: + 44 77 177 84965
Email: [email protected]

About Getinge

Getinge is a global provider of innovative solutions for operating rooms, intensive-care units, sterilization departments and for life science companies and institutions. Based on our first-hand experience and close partnerships with clinical experts, healthcare professionals and medtech specialists, we are improving the every-day life for people, today and tomorrow.

http://news.cision.com/getinge/r/getinge-launches-the-new-advanta-v12---32mm-balloon-expandable-covered-stent-,c2244699

http://mb.cision.com/Main/942/2244699/660959.pdf

(c) 2017 Cision. All rights reserved., source Press Releases - English

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on GETINGE
10/18 GETINGE : publish Interim Report January - September 2017
10/16 GETINGE : Best possible anesthetic care for all patients
10/07 GETINGE : MILITARY $150,000 Federal Contract Awarded to ArjoHuntleigh
10/04 GETINGE : announces date of 2017 Q3 report and conference call
10/03 GETINGE : announces its continued commitment to the European Association for Car..
10/02 GETINGE : announces its continued commitment to the World Federation for Hospita..
09/29 GETINGE : 65-- Water Neutralization Package
09/29 GETINGE : Change in number of shares and votes in Getinge
09/28 GETINGE : The great advantages of Endoscopic Vessel Harvesting
09/26 GETINGE : appoints Interim CFO
More news
News from SeekingAlpha
10/19 Getinge Industrier AB ADR 2017 Q3 - Results - Earnings Call Slides
10/18 Getinge Industrier's (GNGBF) CEO Mattias Perjos on Q3 2017 Results - Earnings..
10/18 Getinge Industrier AB reports Q3 results
07/17 Getinge Industrier's (GNGBF) CEO Mattias Perjos on Q2 2017 Results - Earnings..
07/17 Getinge Industrier AB reports Q2 results
Financials ( SEK)
Sales 2017 30 162 M
EBIT 2017 3 541 M
Net income 2017 1 533 M
Debt 2017 17 368 M
Yield 2017 1,57%
P/E ratio 2017 25,69
P/E ratio 2018 16,42
EV / Sales 2017 1,91x
EV / Sales 2018 1,80x
Capitalization 40 156 M
Chart GETINGE
Duration : Period :
Getinge Technical Analysis Chart | GETI B | SE0000202624 | 4-Traders
Technical analysis trends GETINGE
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 14
Average target price 157  SEK
Spread / Average Target -0,37%
EPS Revisions
Managers
NameTitle
Mattias Sven Perjos President, Chief Executive Officer & Director
Carl Reinhold Adolf Bennet Chairman
Niclas Sjöswärd Chief Financial Officer
Johan Malmquist Director
Johan Bygge Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
GETINGE9.71%4 921
MASIMO CORPORATION28.50%4 500
ASAHI INTECC CO., LTD.29.99%3 534
JIANGSU YUYUE MDCL EQPMNT & SPPLY CO LTD--.--%3 300
PENUMBRA INC49.22%3 227
BIOCARTIS GROUP7.16%618